Gene · 5919
RARRES2: retinoic acid receptor responder 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RARRES2: retinoic acid receptor responder 2. Genes, record 5919. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5919
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q99969 | Retinoic acid receptor responder protein 2 | 163 | 12 | Ensembl, GeneID, HGNC |
Source UniProt
Patents105
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4705329 A1 | 2026-03-11 | 12 | Q99969 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 61516 | Q99969 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 61517 | Q99969 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 61518 | Q99969 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 592 | Q99969 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11244 | Q99969 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11245 | Q99969 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11246 | Q99969 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7526 | Q99969 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7526 | Q99969 | Espacenet |
1 to 10 of 105
See all 105 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants908
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RARRES2 papers | Newest fiscal year |
|---|---|---|---|
| R01AI047822 | Intestinal Lymphocyte Trafficking | 9 | 2025 |
| T32AI007290 | Molecular and Cellular Immunobiology | 9 | 2025 |
| P30DK040561 | Boston Area Nutrition Obesity Research Center (NORC) | 5 | 2025 |
| I01BX004115 | New Approaches to Combat CNS Inflammation: Targeting a Metabolic Enzyme in Demyelinating Disease | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30DK017047 | Diabetes Research Center | 2 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 2 | 2025 |
| P30DK116074 | Stanford Diabetes Research Center | 2 | 2025 |
1 to 10 of 908Source NIH's project files
See all 908 nih grantsPapers2,728
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemerin - CMKLR1 signaling contributes to immune metabolic dysfunction in salt-sensitive hypertension. | Clin Exp Hypertens | 2026 | 42802577 | PubTator, text mining | PubMed |
| Effects of High-Intensity Interval Versus Moderate-Intensity Continuous Training in Adults with Prediabetes: A Single-Blind Randomized Controlled Trial. | J Clin Med | 2026 | 42796049 | PubTator, text mining | PubMed |
| Chemerin and Arterial Stiffness in the Brisighella Heart Study: A Residual-Based Discordance Analysis. | Int J Mol Sci | 2026 | 42794691 | PubTator, text mining | PubMed |
| Immunometabolic Biomarkers in Colorectal Cancer: An Exploratory Diagnostic Evaluation of PBEF/NAMPT, Chemerin, and Osteopontin. | Int J Mol Sci | 2026 | 42794507 | PubTator, text mining | PubMed |
| Tissue-Specific Chemerin in Atherosclerosis. | Biomolecules | 2026 | 42793159 | PubTator, text mining | PubMed |
| Serum Endothelin-1 in Suspected Acute Pulmonary Embolism: A Prospective Study. | J Cardiovasc Dev Dis | 2026 | 42783055 | PubTator, text mining | PubMed |
| Adipokines in preeclampsia: Pathophysiological insights and biomarker potential. | Cytokine | 2026 | 42735512 | PubTator, text mining | PubMed |
| Biomarkers in plasma and extracellular vesicles for early detection of asymptomatic ischemic heart disease: a retrospective case-control study. | Cardiovasc Diagn Ther | 2026 | 42719294 | PubTator, text mining | PubMed |
| Tazarotene-Induced Gene 2 Promotes Melanoma Cell Death via the Activation of Endoplasmic Reticulum Stress. | Front Biosci (Landmark Ed) | 2026 | 42689973 | PubTator, text mining | PubMed |
| Serum Chemerin Concentrations and Tissue Immunoreactivity in Colorectal Adenoma and Colorectal Cancer: An Exploratory Case-Control Study. | Diagnostics (Basel) | 2026 | 42650992 | PubTator, text mining | PubMed |
1 to 10 of 2,728
See all 2,728 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5919
GET https://conductscience.org/api/genes/v1/5919/patents?page=2